Obesity in Diabetes
4
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
6 treatments under study, led by Highdose Vitamin K2 Menaquinone7 90 Mcgd
Research Leaders
8 sponsors active, led by Nordsjaellands Hospital
Related Conditions
Often studied with 16 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
50%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM
Semaglutide Treatment in Type 1 Diabetes
Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)
Obese Patients With Type 2 Diabetes
Research Network
Common Treatments
- Highdose Vitamin K2 Menaquinone7 90 Mcgd1
- Met097 Injection1
- Placebocontrol1
- Lowdose Vitamin K2 Menaquinone7 45mcgd1
- Semaglutide1
Active Sponsors
- Nordsjaellands Hospital1
- Aarhus University Hospital1
- Augusta University1
- Steno Diabetes Center Copenhagen1
- Pfizer1
Top Investigators
Department of Pediatrics, Medical College of Georgia, Augusta University
Nordsjaellands Hospital
Related Conditions
- Obesity2
- Hyperglycemia1
- Nutritional And Metabolic Diseases1
- Diabetes Mellitus Noninsulindependent1
- Lipidomics1